← Back to headlines
Hinge Health Forecasts 2026 Revenue, Launches FDA-Cleared Migraine Program
Hinge Health projected its 2026 revenue to be between $798 million and $804 million, while also announcing the launch of its FDA-cleared Enso migraine program.
6 May, 04:42 — 6 May, 04:42
Sources
Showing 1 of 1 sources
